Balancing efficacy of and host immune responses to cancer therapy: the yin and yang effects
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
http://www.nature.com/articles/nrclinonc.2016.57.pdf
Reference212 articles.
1. Baldo, B. A. & Pagani, M. Adverse events to nontargeted and targeted chemotherapeutic agents: emphasis on hypersensitivity responses. Immunol. Allergy Clin. North Am. 34, 565–596 (2014).
2. Chen, H. X. & Cleck, J. N. Adverse effects of anticancer agents that target the VEGF pathway. Nat. Rev. Clin. Oncol. 6, 465–477 (2009).
3. Jean, G. W. & Shah, S. R. Epidermal growth factor receptor monoclonal antibodies for the treatment of metastatic colorectal cancer. Pharmacotherapy 28, 742–754 (2008).
4. Tranchand, B., Laporte, S., Glehen, O. & Freyer, G. Pharmacology of cytotoxic agents: a helpful tool for building dose adjustment guidelines in the elderly. Crit. Rev. Oncol. Hematol. 48, 199–214 (2003).
5. Canal, P., Chatelut, E. & Guichard, S. Practical treatment guide for dose individualisation in cancer chemotherapy. Drugs 56, 1019–1038 (1998).
Cited by 100 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Combining spatially fractionated radiation therapy (SFRT) and immunotherapy opens new rays of hope for enhancing therapeutic ratio;Clinical and Translational Radiation Oncology;2024-01
2. The role of host response to chemotherapy: resistance, metastasis and clinical implications;Clinical & Experimental Metastasis;2023-11-24
3. Case report: Dendritic cell-cytokine induced killer cell therapy in subjects with chronic lymphocytic leukemia and peritoneal cancer;Frontiers in Medicine;2023-10-09
4. Normalizing Tumor Blood Vessels to Improve Chemotherapy and Inhibit Breast Cancer Metastasis by Multifunctional Nanoparticles;Molecular Pharmaceutics;2023-09-20
5. Promotion of tumor angiogenesis and growth induced by low-dose antineoplastic agentsviabone-marrow-derived cells;2023-08-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3